Drug Shortage Report for MYLAN-RISPERIDONE

Last updated on 2017-10-04 History
Report ID 5338
Drug Identification Number 02282275
Brand name MYLAN-RISPERIDONE
Common or Proper name RISPERIDONE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RISPERIDONE
Strength(s) 2.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-06-11
Actual start date 2017-07-06
Estimated end date
Actual end date 2017-10-02
Shortage status Resolved
Updated date 2017-10-04
Company comments Discontinuation reported under ID 16163.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2017-10-04 French Compare
v21 2017-10-04 English Compare
v20 2017-10-04 French Compare
v19 2017-10-04 English Compare
v18 2017-10-03 English Compare
v17 2017-10-02 French Compare
v16 2017-10-02 English Compare
v15 2017-07-07 French Compare
v14 2017-07-07 English Compare
v13 2017-07-07 French Compare
v12 2017-07-07 English Compare
v11 2017-07-07 English Compare
v10 2017-06-12 English Compare
v9 2017-05-04 French Compare
v8 2017-05-04 English Compare
v7 2017-04-13 French Compare
v6 2017-04-13 English Compare
v5 2017-04-04 French Compare
v4 2017-04-04 English Compare
v3 2017-04-04 English Compare

Showing 1 to 20 of 22